Need a specific person's email?
Browse Novartis Gene Therapies's employee directory (about 1K employees) and reveal verified emails free.
Novartis Gene Therapies's most common email format is First.Last@novartis.com (ex. John.Doe@novartis.com), used for 89% of novartis.com addresses. Novartis Gene Therapies uses 4 email patterns.
| Format | Example | Share of novartis.com |
|---|---|---|
| First.Last@novartis.comMost common | John.Doe@novartis.com | |
| F.Last@novartis.com | J.Doe@novartis.com | |
| FiLast@novartis.com | JoDoe@novartis.com | |
| FLast@novartis.com | JDoe@novartis.com |
Browse Novartis Gene Therapies's employee directory (about 1K employees) and reveal verified emails free.
Biotechnology ResearchIllinois, United States1001-5000 Employees
Novartis Gene Therapies is a unit within Novartis operating in the biotechnology research industry, focused on developing gene therapies for rare genetic diseases. It aims to translate promising gene therapies into validated treatments, with spinal muscular atrophy (SMA) highlighted as its leading program after rebranding from AveXis. The company is based in Bannockburn, Illinois, and operates as part of a broader pharmaceutical landscape. Its work targets people living with rare genetic conditions and the clinicians who diagnose and treat them, seeking to address meaningful unmet medical needs. Positioned within biotechnology and gene therapy development, the unit reflects Novartis' portfolio strategy in this field. The organization maintains a sizable workforce, underscoring its scale within the sector.
Most common format
First.Last@novartis.com
Example: John.Doe@novartis.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.